Medical/Pharmaceuticals

/C O R R E C T I O N -- Oxford Orthopaedics/

We are advised by the client that there are several changes in the release content. The complete, corrected version of the news release issued onSeptember 22, 2021 by Oxford Orthopaedics over PR Newswire is as follows: 1cm "Lasso" Technique for Ankle Ligament Reconstruction, Developed by Drs Tay ...

2021-09-28 19:24 2070

Xiaobai Maimai Plans to Enter the U.S. Radiation Oncology Services Market

BEIJING, Sept. 28, 2021 /PRNewswire/ -- Xiaobai Maimai Inc. (NASDAQ: HX) ("Xiaobai Maimai", the "Company", or "we"), a social e-commerce platform in China, today announced that it plans to enter the radiation oncology services market in the U.S. The Company recently established We Health Limited...

2021-09-28 19:00 8689

Zymo Research Pays it Forward With Their Commitment to Eradicate the COVID-19 Pandemic in India

DNA/RNA Shield – DirectDetect™ reagent eliminates RNA extraction for rapid deployment of COVID-19 tests in affected countries IRVINE, Calif., Sept. 28, 2021 /PRNewswire/ -- Zymo Research has donated one million COVID-19 test kits that include its newDNA/RNA Shield - DirectDetect™ reagent and col...

2021-09-28 14:57 3605

LTI and eClinicalHealth Form Strategic Partnership to Accelerate Innovation in Clinical Research

- Partnership to help decentralize clinical trials resulting in better and faster outcomes MUMBAI, India, Sept. 28, 2021 /PRNewswire/ -- Larsen & Toubro Infotech (BSE: 540005) (NSE: LTI), a global technology consulting and digital solutions company has entered in a...

2021-09-28 14:12 5074

Brii Bio Appoints Coy Stout as Senior Vice President and Head of U.S. Market Access and Patient Advocacy

DURHAM, N.C. and BEIJING, Sept. 28, 2021 /PRNewswire/ -- Brii Biosciences Limited ("Brii Bio" or the "Company", stock code: 2137.HK) a multi-national company developing innovative therapies for diseases with significant unmet medical needs and large public heal...

2021-09-28 08:00 6175

Innovent and UNION Therapeutics Enter into Strategic Collaboration and License Agreement for Orismilast, a Next-generation PDE4 Inhibitor for Inflammatory Dermatology Conditions

SAN FRANCISCO and SUZHOU, China and HELLERUP, Denmark, Sept. 28, 2021 /PRNewswire/ -- Innovent Biologics, Inc. (Innovent) (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high quality medicines for the treatment of cancer, metabolic, autoimmun...

2021-09-28 08:00 4768

LifeWave Notches Prestigious Inc. 5000 Distinction for the 4th time with Fast Growth and Bold Product Innovation

TOKYO, Sept. 28, 2021 /PRNewswire/ -- Cutting-edge health technology company, LifeWave, has solidified its place as one of America's fastest growing privately held companies by again making theInc. 5000 list for 2021. Released in mid-August, the publication asserts that "brains, bravery, and opti...

2021-09-28 06:46 3975
1 ... 639640641642643

Week's Top Stories